CPT Code 52332: A Comprehensive Guide to Ureteral Stent Placement Coding, Procedures, and Complications

Imagine a critical, narrow highway that is the sole route for transporting essential goods from a major production facility. Now, imagine a traffic jam, a landslide, or a structural failure blocking that highway. The entire system grinds to a halt, pressure builds catastrophically, and without immediate intervention, the resulting damage can be severe and permanent. This is a fitting analogy for the human ureter—the slender, muscular tube that acts as a vital conduit, transporting urine from the kidney to the bladder. When this pathway is obstructed by a kidney stone, a tumor, or a stricture, the consequences are acutely painful and medically urgent. The backup of urine, known as hydronephrosis, can destroy kidney function in a matter of days.

In the world of urology, one of the most fundamental and life-preserving interventions for such an obstruction is the placement of a ureteral stent. This simple, flexible, and ingeniously designed tube becomes a new internal bypass, re-establishing drainage and protecting renal function. For physicians, it is a routine procedure. For patients, it is often a profound relief. And for medical coders, billers, and healthcare administrators, it is represented by a precise and nuanced Current Procedural Terminology (CPT) code: 52332.

This article serves as the ultimate guide to CPT code 52332. We will journey beyond the five-digit number to explore the intricate anatomy, the compelling medical indications, the detailed steps of the procedure itself, and the complex landscape of medical coding that surrounds it. Our goal is to synthesize clinical understanding with coding expertise, providing a resource that is invaluable for urologists, coders, billers, students, and healthcare administrators alike. By understanding what happens in the procedure room, we can more accurately and ethically represent it on the claim form, ensuring compliant reimbursement and supporting the vital work of urologic care.

2. Anatomy and Physiology: Understanding the Ureter’s Role

To truly appreciate the function of a ureteral stent, one must first understand the anatomy it is designed to support. The urinary system is elegantly simple in its design: two kidneys, two ureters, one bladder, and one urethra.

The ureters are the critical link between the kidneys and the bladder. Each is approximately 22-30 cm long in adults and only 3-4 mm in diameter—no wider than a strand of spaghetti. They are not passive pipes but dynamic, muscular structures. Their walls are composed of smooth muscle fibers that undergo peristaltic waves—rhythmic contractions—to actively propel urine from the renal pelvis down into the bladder.

Anatomically, the ureter has three natural constrictions where stones are most likely to become lodged:

1. Ureteropelvic Junction (UPJ): Where the renal pelvis funnels down into the ureter.

2. Crossing of the Iliac Vessels: Where the ureters cross over the common iliac arteries and veins at the pelvic brim.

3. Ureterovesical Junction (UVJ): The point where the ureter tunnels obliquely through the wall of the bladder. This one-way valve mechanism is crucial; it prevents the backflow of urine from the bladder to the kidneys when bladder pressure increases during voiding.

The ureter’s blood supply is segmental, deriving from multiple arteries (renal, gonadal, common iliac, vesical), making it susceptible to ischemic injury if dissected or handled improperly during surgery. This intricate anatomy explains why ureteral stents must be so flexible yet resilient, and why their placement requires precision and skill.

3. The Ureteral Stent: Design, Materials, and Types

A ureteral stent, also known as a double-J stent or pig-tail stent, is a specially designed catheter placed in the ureter. The name “double-J” comes from its signature shape: both the proximal (kidney) end and the distal (bladder) end are coiled into a “J” shape. This design is not aesthetic; it is functional. The curls act as anchors, preventing the stent from migrating up or down out of its intended position.

Materials:
Modern stents are typically made from biocompatible polymers such as silicone, polyurethane, or a proprietary copolymer like Percuflex®. These materials are chosen for their:

• Flexibility: To conform to the tortuous path of the ureter and minimize irritation.

• Durability: To resist encrustation from minerals in the urine for the duration of implantation.

• Biocompatibility: To minimize inflammatory reactions from the body.

Design Variations:

• Standard Double-J Stents: The most common type, with multiple side holes along its length to facilitate urine drainage.

• Open-Ended Stents: Often used when a string is left attached for subsequent office-based removal. The distal end is not closed off.

• Multicoil Stents: Feature a larger, more complex coil on the bladder end, theorized to reduce bladder irritation.

• Metal Stents: Used for malignant obstructions, these self-expanding mesh stents (e.g., Resonance® stent) are designed for long-term patency and are not easily encrusted.

• Specialty Stents: Include designs with anti-reflux mechanisms or those made from biodegradable materials that dissolve over time, eliminating the need for a removal procedure.

The choice of stent depends on the indication for placement, the anticipated duration of stenting, and surgeon preference.

4. Indications for Ureteral Stent Placement: When is it Necessary?

Ureteral stenting is a therapeutic solution to a problem of obstruction or leakage. The decision to place a stent is based on a combination of patient symptoms, imaging findings, and underlying pathology.

1. Obstruction:

• Nephrolithiasis (Kidney Stones): The most common indication. A stent is placed to bypass an obstructing stone, relieving pain and hydronephrosis, often before definitive stone treatment like lithotripsy.

• Malignant Obstruction: Tumors from cancers like cervical, prostate, bladder, or colorectal can compress or invade the ureters externally.

• Benign Strictures: Scar tissue can narrow the ureter from within, caused by previous surgery, radiation therapy, or inflammatory conditions.

• Retroperitoneal Fibrosis: A rare condition where fibrous tissue encases the ureters, pulling them medially and causing obstruction.

2. Post-Procedural / Surgical:

• After Ureteroscopy: Stenting is common after stone manipulation to ensure drainage despite post-procedural edema.

• After Endopyelotomy: A procedure to incise a stenotic UPJ requires stenting to allow healing over a scaffold.

• After Renal Transplant: To protect the anastomosis between the transplant ureter and the bladder.

3. Other Indications:

• Ureteral Injury: To allow healing of a traumatic or iatrogenic (surgery-related) injury to the ureter.

• Fistula Prevention: To divert urine flow away from a healing anastomosis, as in a urinary diversion surgery.

• Access for Chemotherapy: To provide a conduit for topical chemotherapeutic agents in certain bladder cancers.

5. The Procedure: A Step-by-Step Walkthrough of Cystoscopic Stent Placement

The placement of a ureteral stent via cystoscopy, which is described by CPT 52332, is a meticulous process. It is typically performed under general or spinal anesthesia, though sedation can be used for some patients.

Step 1: Patient Preparation and Positioning
The patient is placed in the dorsal lithotomy position (on their back with legs raised and supported in stirrups). The genitalia are cleansed with an antiseptic solution, and sterile drapes are applied.

Step 2: Cystourethroscopy
The urologist introduces a cystoscope—a rigid or flexible tubular instrument with a lens and light source—through the urethra and into the bladder. Saline solution is irrigated through the scope to distend the bladder, providing a clear view of the bladder mucosa. The urologist performs a systematic inspection of the bladder walls, trigone, and urethral orifices.

Step 3: Identifying the Ureteral Orifice
Using the cystoscope, the urologist locates the ureteral orifice—the slit-like opening where the ureter enters the bladder. This is often found on the trigone at the corners of the interureteric ridge.

Step 4: Cannulating the Ureter
A thin, flexible guidewire is advanced through the working channel of the cystoscope. Under direct vision, the tip of the guidewire is carefully inserted into the ureteral orifice and advanced up the ureter, past the point of obstruction, and into the renal pelvis. Fluoroscopy (live X-ray) is almost always used during this step to confirm the wire’s position and navigate any obstructions.

Step 5: Stent Placement Over the Guidewire
The cystoscope is removed, leaving the guidewire in place, traversing the urethra and ureter. The chosen ureteral stent is then threaded over the proximal end of the guidewire. A pusher catheter is used to advance the stent along the wire, under fluoroscopic guidance. The urologist watches as the proximal coil forms in the renal pelvis.

Step 6: Deploying the Distal Coil and Removing the Guidewire
Once the proximal coil is confirmed to be in a good position, the guidewire is slowly withdrawn. As it is pulled back, the distal end of the stent, now free from the constraint of the wire, naturally coils up inside the bladder.

Step 7: Final Inspection and Conclusion
The cystoscope may be reinserted to visually confirm the position of the distal coil in the bladder, ensuring it is not protruding into the urethra. All instruments are removed. The procedure is complete. A Foley catheter may be placed temporarily, depending on the clinical scenario.

6. CPT Code 52332: Deep Dive into Cystourethroscopy with Ureteral Stent Placement

The CPT codebook is the definitive source for procedural coding. The code that accurately describes the procedure detailed above is:

CPT 52332: Cystourethroscopy, with insertion of indwelling ureteral stent (eg, Gibbons or double-J type)

Let’s deconstruct the official code descriptor:

• Cystourethroscopy: This defines the approach. The procedure is performed from within, via the urethra. This is a key differentiator from percutaneous approaches.

• With insertion: This is a placement service. It includes the entire process from start to finish.

• Indwelling ureteral stent: This specifies the device being placed. “Indwelling” means it is intended to be left inside the body after the procedure.

• eg, Gibbons or double-J type: These are examples of stent types, confirming that this code is not for temporary catheters used only during a procedure.

What is included in 52332?
The code is a “package.” It includes all the work inherent to the procedure:

• Passage of the cystoscope through the urethra into the bladder.

• Inspection of the bladder (diagnostic cystoscopy).

• Cannulation of the ureteral orifice with a guidewire.

• Fluoroscopic guidance to position the wire and stent.

• Placement of the stent over the wire.

• Removal of the wire and final positioning of the stent.

• Any balloon dilation of the ureteral orifice performed at the same time to facilitate stent placement.

What is not included?
The code describes a unilateral service. If a stent is placed in both the left and right ureters during the same session, it is not reported twice. Modifiers are required (see section 7).

7. Modifiers and Bundling: Navigating the Nuances of Accurate Billing

Modifiers are two-character suffixes that provide additional information about a service performed. Their correct use is critical for ethical billing and avoiding denials or audits.

Modifier -50 (Bilateral Procedure)
If the physician places an indwelling ureteral stent in both the left and right ureters during the same operative session, CPT 52332 is reported once with modifier -50 appended.

• Example: 52332-50

• Reimbursement: Typically, the payer will reimburse 150% of the allowable fee for the unilateral procedure (100% for the first side, 50% for the second).

Modifier -51 (Multiple Procedures)
This modifier is used when multiple distinct procedures are performed during the same surgical session. If 52332 is performed along with another, unrelated procedure (e.g., a bladder biopsy – 52204), the secondary, less resource-intensive procedure is appended with modifier -51.

• Coding Tip: Payers often automatically apply -51 based on their own rules. Check payer-specific guidelines.

Modifier -59 (Distinct Procedural Service)
This is a powerful and often misused modifier. It indicates that a procedure was distinct or independent from other services performed on the same day. Its use with 52332 is rare but could apply in a highly unusual scenario where two separate stents are placed in the same ureter for distinct reasons during the same session. Its primary use is to bypass National Correct Coding Initiative (NCCI) edits.

NCCI Edits and Bundling:
The Centers for Medicare & Medicaid Services (CMS) developed the NCCI to prevent improper payment for services that should not be reported together. Many endoscopic procedures are bundled into 52332 because they are considered integral to the access and placement.

• Cystoscopy (52000): Always bundled. It is included in 52332.

• Ureteroscopy (52320-52355): If a ureteroscopy with stone manipulation is performed, the stent placement is often bundled. However, if the stent is placed for a separate, pre-existing obstruction after the stone from a different site is treated, modifier -59 may be justified. Documentation must clearly support the medical necessity of two separate procedures.

 Common Modifiers for CPT 52332

Modifier	Code Example	Description	Use Case
-50	52332-50	Bilateral Procedure	Stent placed in both the left and right ureter during the same session.
-51	52204-51	Multiple Procedures	52332 is primary procedure; a bladder biopsy (52204) is performed secondarily.
-59	52332-59, 52353	Distinct Procedural Service	Rare. To indicate stent placement was for a reason wholly separate from another ureteroscopic procedure performed.
-LT / -RT	52332-LT	Left / Right Side	Used by some payers instead of -50 for bilateral services. Always check guidelines.

8. Common Pitfalls and Audit Triggers in Coding 52332

Miscoding 52332 can lead to claim denials, recoupments, and even allegations of fraud. Awareness of these common pitfalls is the first step toward prevention.

1. Unbundling: Reporting a diagnostic cystoscopy (52000) in addition to 52332. This is a classic unbundling error, as the cystoscopy is a necessary component of the stent placement.

2. Incorrect Bilateral Billing: Reporting 52332 twice (e.g., 52332, 52332) for a bilateral procedure instead of using 52332-50.

3. Lack of Medical Necessity: The medical record must clearly document the reason for the stent placement (e.g., “obstructing 8mm stone at left UVJ with significant hydronephrosis on CT scan”). Without strong documentation, the service may be deemed not medically necessary.

4. Confusing with Other Codes:

   • CPT 52334 (Cystourethroscopy with ureteral catheterization): This is for a temporary catheter placed for a pyelogram or collecting a urine sample. It is not for an indwelling stent.

   • CPT 50605 (Insertion of ureteral stent, percutaneous): This is for a stent placed through the skin of the back into the kidney, not via the urethra. The approach is completely different.

5. Poor Documentation of Fluoroscopy: While the use of fluoro is included in 52332, its use should still be documented in the procedure note to support the medical complexity of the case.

9. Global Periods and Reimbursement Considerations

CPT 52332 is a surgical procedure with a 0-day global period. This means that the reimbursement for the code includes only the procedure itself. Any related Evaluation and Management (E/M) services provided on the same day are generally not separately billable unless they are significant, separately identifiable, and performed for a reason unrelated to the decision to perform the stent placement. In such cases, modifier -25 must be appended to the E/M code, and the documentation must substantiate the distinct nature of the service.

Reimbursement rates vary significantly by payer (Medicare, Medicaid, private insurance) and geographic region based on the Medicare Physician Fee Schedule’s Geographic Practice Cost Indices (GPCIs). The value of the code is derived from the physician work, practice expense, and professional liability insurance (malpractice) costs associated with the service.

10. Stent Removal: Coding for the Conclusion of Care (CPT 52310)

Ureteral stents are not meant to be permanent. They are typically removed or exchanged every 3-6 months to prevent encrustation and infection. The code for removal is:

CPT 52310: Cystourethroscopy, with removal of foreign body, calculus, or ureteral stent from urethra or bladder

Removal is often a simpler procedure. It can be performed in the office with a flexible cystoscope, often with local anesthetic gel. If a string was left attached to the stent at placement (often done for short-term stents in women), removal can be as simple as pulling the string. Without a string, the urologist uses a grasping instrument through the cystoscope to grab the distal end of the stent and pull it out.

It is crucial to note that if the stent is removed during the postoperative period of the original placement surgery (e.g., if placed after a ureteroscopy with a 10-day global period), the removal is included in the global surgical package and is not separately billable.

11. Alternative Approaches: Percutaneous and Intraoperative Stenting

While 52332 describes a retrograde (through the urethra) approach, stents can be placed via other methods, each with its own CPT code.

Percutaneous Nephrostomy with Stent Placement:
For complex obstructions that cannot be bypassed from below, an interventional radiologist or urologist may place a nephrostomy tube. This is a catheter inserted directly through the skin on the patient’s flank into the renal pelvis. Sometimes, this access is used to place a stent in an antegrade fashion (from the kidney down to the bladder). This is coded as:

• CPT 50605: Insertion of ureteral stent, percutaneous, including nephrostomy

Open or Laparoscopic Stent Placement:
During an open abdominal or laparoscopic surgery (e.g., a hysterectomy or colectomy), a urologist may be consulted to place stents to identify and protect the ureters from injury. This is typically not coded separately. Placing stents for identification is considered an integral part of the larger surgical procedure and is bundled into the primary surgery’s code.

12. Patient Experience: Living with a Stent and Managing Symptoms

For many patients, while the stent resolves the dangerous obstruction, it introduces a new set of challenging symptoms. Common issues include:

• Urinary Frequency and Urgency: The stent irritates the bladder wall, mimicking a constant feeling of needing to void.

• Dysuria: Pain or burning with urination.

• Hematuria: Blood in the urine, especially after physical activity, is very common.

• Flank Pain: Particularly during voiding, as urine can reflux back up the stent into the kidney (vesicoureteral reflux).

• Body Awareness: A constant feeling of fullness or discomfort.

Management involves hydration, analgesics (like phenazopyridine for bladder discomfort), and sometimes anticholinergic medications to calm bladder spasms. Patient education is crucial to set expectations and improve quality of life during the stenting period.

13. Complications of Ureteral Stents: Identification and Management

While life-saving, stents are foreign bodies and carry risks.

• Migration: The stent can shift position, becoming ineffective or causing pain.

• Encrustation: Minerals in the urine can crystallize on the stent’s surface, making it difficult or even dangerous to remove if left in too long.

• Fracture: A rare but serious complication where the stent breaks upon removal.

• Infection: Can lead to cystitis or, more seriously, pyelonephritis.

• Forgotten Stent: The most serious complication is a stent that is not removed or exchanged on schedule, leading to severe encrustation, obstruction, and potential loss of the kidney. Robust tracking systems are essential in urology practices.

14. The Future of Ureteral Stenting: Technological Advancements

Research is focused on improving patient comfort and reducing complications.

• Biodegradable Stents: Stents made from materials that dissolve after a predetermined time, eliminating the need for a removal procedure.

• Drug-Eluting Stents: Stents coated with medications (e.g., antibiotics to prevent infection, anticholinergics to reduce spasms, or inhibitors to prevent encrustation).

• “Smarter” Stents: Stents with built-in sensors to monitor renal pressure or temperature, providing data on kidney function remotely.

15. Conclusion: Synthesizing Clinical and Coding Expertise

CPT code 52332 represents far more than a simple billing code; it encapsulates a critical urologic intervention that relieves suffering and preserves renal function. Accurate coding hinges on a deep understanding of the clinical procedure, its indications, and its inherent components. By mastering the nuances of modifiers, bundling rules, and documentation requirements, healthcare professionals can ensure compliant and ethical reimbursement. Ultimately, precise coding for this essential service supports the financial viability of urologic practices, allowing them to continue providing high-quality care to patients in need.

16. Frequently Asked Questions (FAQs)

Q1: Can I bill for both a ureteroscopy (e.g., 52353 for lithotripsy) and a stent placement (52332) during the same surgery?
A: Typically, no. NCCI edits bundle the stent placement into the ureteroscopy code, as it is considered a routine part of the procedure. However, if the stent is placed for a separate, pre-existing obstruction (not related to the stone just treated), modifier -59 may be justified with profound documentation.

Q2: How do I code for a stent exchange?
A: An exchange involves both a removal and a new placement. You would report 52310 (removal of old stent) and 52332 (insertion of new stent). Modifier -51 may need to be appended to the second code.

Q3: Is fluoroscopy separately billable with 52332?
A: No. The use of fluoroscopic guidance for the placement of the guidewire and stent is considered an integral part of the procedure and is included in the description of 52332.

Q4: What is the difference between CPT 52332 and CPT 52334?
A: 52332 is for an indwelling stent (e.g., double-J) left inside the body. 52334 is for temporary ureteral catheterization, such as placing a catheter for a retrograde pyelogram to obtain images; this catheter is removed at the conclusion of that procedure.

Q5: A patient has a stent placed. Later the same day, they present to the ER with severe colic. Can the ER visit be billed?
A: Possibly, if the ER visit is for a unrelated issue. However, if the visit is for a complication or expected symptom of the stent itself (e.g., severe pain, bleeding), it is likely bundled into the procedure’s global period (which is 0 days for 52332, so after the day of surgery, it may be billable with good documentation).

17. Additional Resources

1. American Medical Association (AMA): For the purchase of the official CPT® codebook and updates. www.ama-assn.org

2. Centers for Medicare & Medicaid Services (CMS): For NCCI edits, the Medicare Physician Fee Schedule Look-Up Tool, and official manuals. www.cms.gov

3. American Urological Association (AUA): Provides excellent clinical guidelines, coding seminars, and practice resources for urology-specific issues. www.auanet.org

4. Society of Urologic Nurses and Associates (SUNA): Provides patient education materials and clinical practice information. www.suna.org

 

Date: September 4, 2025
Author: The Medical Coding Specialist
Disclaimer: This article is intended for informational and educational purposes only. It does not constitute medical, legal, or coding advice. While every effort has been made to ensure accuracy, CPT codes are proprietary to the American Medical Association (AMA), and users must consult the most current, official AMA CPT code books and payer-specific guidelines for accurate billing and reimbursement. Always consult with a qualified healthcare professional for any medical concerns.